Jacobs Levy Equity Management
TCRX icon

Jacobs Levy Equity Management’s TScan Therapeutics TCRX Stock Holding History

Jacobs Levy Equity Management’s Portfolio TCRX Stock Details TCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-18,951
Closed -$57.6K – 1197
2024
Q4 		$57.6K Sell
18,951
-84,489
-82% -$257K ﹤0.01% 922
2024
Q3 		$515K Buy
+103,440
New +$515K ﹤0.01% 828